P
Peter L. Lakatos
Researcher at Semmelweis University
Publications - 641
Citations - 27791
Peter L. Lakatos is an academic researcher from Semmelweis University. The author has contributed to research in topics: Inflammatory bowel disease & Population. The author has an hindex of 73, co-authored 562 publications receiving 23836 citations. Previous affiliations of Peter L. Lakatos include University of Debrecen & Montreal General Hospital.
Papers
More filters
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping Chung Leung,Z. Man,Carlos Mautalen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: Treatment with zoledronic acid reduced the risk of morphometric vertebral fracture by 70% during a 3-year period, as compared with placebo.
Journal ArticleDOI
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Laurent Peyrin-Biroulet,William J. Sandborn,Bruce E. Sands,Walter Reinisch,Walter Reinisch,Willem A. Bemelman,Robert V Bryant,G R D’Haens,Iris Dotan,Marla Dubinsky,Brian G. Feagan,Gionata Fiorino,Richard B. Gearry,S. Krishnareddy,Peter L. Lakatos,Edward V. Loftus,P. Marteau,Pia Munkholm,Travis B. Murdoch,Ingrid Ordás,Remo Panaccione,Robert H. Riddell,J. Ruel,David T. Rubin,Mark A Samaan,Corey A. Siegel,Mark S. Silverberg,Jaap Stoker,Stefan Schreiber,Simon Travis,G. Van Assche,G. Van Assche,Silvio Danese,Julián Panés,Guillaume Bouguen,Sarah O’Donnell,Benjamin Pariente,S. Winer,Stephen B. Hanauer,J.-F. Colombel +39 more
TL;DR: Evidence- and consensus-based recommendations for selecting the goals for treat-to-target strategies in patients with IBD are made available and future studies are needed to determine how these targets will change disease course and patients’ quality of life.
Journal ArticleDOI
The burden of inflammatory bowel disease in Europe.
TL;DR: The aim of this review is to describe the burden of IBD in Europe by discussing the latest epidemiological data, the disease course and risk for surgery and hospitalization, mortality and cancer risks, as well as the economic aspects, patients' disability and work impairment.
Journal ArticleDOI
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black,Pierre D. Delmas,Richard Eastell,Ian R. Reid,Steven Boonen,Jane A. Cauley,Felicia Cosman,Peter L. Lakatos,Ping-Chung Leung,Z. Man,Carlos Mautallen,Peter Mesenbrink,Huilin Hu,John Caminis,Karen Tong,Theresa Rosario-Jansen,Joel S. Krasnow,Trisha F. Hue,Deborah E. Sellmeyer,Erik Fink Eriksen,Steven R. Cummings +20 more
TL;DR: A once-yearly infusion of zoledronic acid during a 3-year period significantly reduced the risk of vertebral, hip, and other fractures and was associated with a significant improvement in bone mineral density and bone metabolism markers.
Journal ArticleDOI
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.
Angelo Agostoni,Emel Aygören-Pürsün,Karen Binkley,Alvaro Blanch,Konrad Bork,Laurence Bouillet,Christoph Bucher,Anthony J. Castaldo,Marco Cicardi,Alvin E. Davis,Caterina De Carolis,Christian Drouet,Christiane Duponchel,Henriette Farkas,Kalman Fay,Béla Fekete,Bettina Fischer,Luigi Fontana,George Füst,Roberto Giacomelli,Albrecht Gröner,C. Erik Hack,George Harmat,John Jakenfelds,Mathias Juers,Lajos Kalmar,Pál Novák Kaposi,István Karádi,Arianna Kitzinger,Tímea Kollár,Wolfhart Kreuz,Peter L. Lakatos,Hilary Longhurst,Margarita López-Trascasa,Inmaculada Martinez-Saguer,Nicole Monnier,István Nagy,Éva Németh,Erik Waage Nielsen,Jan H. Nuijens,Caroline O'Grady,Emanuela Pappalardo,Vincenzo Penna,Carlo Perricone,Roberto Perricone,Ursula Rauch,Olga Roche,E. Rusicke,Peter J. Späth,George Szendei,Edit Takács,Attila Tordai,Lennart Truedsson,Lilian Varga,Beáta Visy,Kayla Williams,Andrea Zanichelli,Lorenza C. Zingale +57 more
TL;DR: This supplement contains work presented at the third workshop and expanded content toward a definitive picture of angioedema in the absence of allergy, and includes cumulative genetic investigations; multinational laboratory diagnosis recommendations; current pathogenesis hypotheses; and suggested prophylaxis and acute attack treatment.